Soothing sensitive skin
Conditions
Interventions
Facial test group:There is only an experimental group on the face, without control group. Compare before and after use, and use the test product on the face. The testing time is D0, D3, and D7.
Test group(Arm):Skin injury model was created on the arm, with a total of three experimental areas. After modeling the arm injury, apply the test product to one of the test areas according to the rand
Positive control group (Arm):Skin injury model was created on the arm, with a total of three experimental areas. After modeling the arm injury, apply tacrolimus ointment to one of the experimental are
Negative control group (Arm):Skin injury model was created on the arm, with a total of three experimental areas. After modeling the arm injury, according to the random table, do not use the product in
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1) Age = 18 years old, = 60 years old, both male and female; 2) Good health condition; 3) The total positive score of lactate stinging test is = 3 points; 4) Willing to comply with the experimental requirements and complete the entire experiment for a total of 4 weeks, able to complete follow-up as required 5) Informed consent for the project and signing of informed consent and portrait rights consent forms
Exclusion criteria
Exclusion criteria: 1) Pregnant or lactating women; 2) Skin diseases (such as psoriasis, eczema, psoriasis, skin cancer, etc.), or obvious redness, sunburn, wounds, wear, tattoos, etc. in or near the testing area; 3) Participated in similar tests within 3 months; 4) Use any other anti allergic products within the past 3 months; 5) Participate in other clinical trial researchers; 6) Experts or professionals believe that there are other iatrogenic factors that may affect the test results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Loss of moisture through the epidermis(Face);Current sensing threshold(Face);Blood flow perfusion volume(Face);Lactic acid stinging pain(Face);a value(Face and Arm); | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety assessment(Face and Arm); | — |
Countries
China
Contacts
Public ContactWang Xi
West China Hospital, Sichuan University
Outcome results
None listed